EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, DXS International's Enterprise Value is €0.79 Mil.
DXS International's Free Cash Flow for the trailing twelve months (TTM) ended in Apr. 2025 was €0.46 Mil. Therefore, DXS International's EV-to-FCF for today is 1.70.
The historical rank and industry rank for DXS International's EV-to-FCF or its related term are showing as below:
STU:7EE'
s EV-to-FCF Range Over the Past 10 Years
Min: -199.44 Med: -5.64 Max: 70.04
Current: 2.13
During the past 11 years, the highest EV-to-FCF of DXS International was 70.04. The lowest was -199.44. And the median was -5.64.
STU:7EE's EV-to-FCF is ranked better than 93.83% of 405
companies
in the Healthcare Providers & Services industry
Industry Median: 17.66
vs STU:7EE: 2.13
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
DXS International's PE Ratio (TTM) for today is calculated as:
DXS International's share price for today is €0.011.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. DXS International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2025 was €-0.001.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
DXS International EV-to-FCF Related Terms
DXS International EV-to-FCF Historical Data
* Premium members only.
The historical data trend for DXS International's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, DXS International's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DXS International EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DXS International's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where DXS International's EV-to-FCF falls into.
DXS International's current Enterprise Value is €0.79 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. DXS International's Free Cash Flow for the trailing twelve months (TTM) ended in Apr. 2025 was €0.46 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DXS International (STU:7EE) has a EV-to-FCF of 1.70 as of Jul. 07, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on DXS International and its competitors. According to the industry distribution chart, DXS International ranks #25 out of 405 companies in the Healthcare Providers & Services industry, placing it in the top 6.2%.
Is DXS International's EV-to-FCF too high?
DXS International's current EV-to-FCF is 1.70. The Healthcare Providers & Services industry median EV-to-FCF is 17.66. DXS International's value of 1.70 is 90.4% below this industry median. Based on the distribution chart, DXS International ranks #25 out of 405 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, DXS International has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does DXS International's EV-to-FCF compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, DXS International ranks #25 out of 405 companies for EV-to-FCF. This places DXS International in the top 6% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 17.66. DXS International's value of 1.70 is 90.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.66, based on 405 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DXS International's current EV-to-FCF of 1.70 is 90.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on DXS International and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DXS International's current EV-to-FCF is 1.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DXS International stock overvalued right now?
DXS International (STU:7EE) has a current EV-to-FCF of 1.70. The stock's GF Value™ is €0.02, compared to a current price of €0.01 — trading 45% below its estimated fair value. The current EV-to-FCF is 1.70 and 90.4% below the Healthcare Providers & Services industry median of 17.66. DXS International's overall GF Score™ is 39/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For DXS International (STU:7EE), the current EV-to-FCF is 1.70 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DXS International (STU:7EE) Overvalued in 2026?
Based on GuruFocus' analysis, DXS International stock appears to be undervalued.
The current stock price of €0.01 is trading 45% below its estimated GF Value™ of €0.02.
Key valuation signals for STU:7EE:
EV-to-FCF: 1.70
GF Value™: €0.02 vs. price of €0.01 (45% below fair value)
Industry Position: 90.4% below the Healthcare Providers & Services median (#25 of 405)
No single metric tells the full story. See the STU:7EE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DXS International PLC is engaged in the development and distribution of clinical decision support systems for General Practitioners, nurses, and retail pharmacies in the United Kingdom and South Africa. Its commercial activities include licensing DXS products to various ICBs, offering e-detailing opportunities to the pharmaceutical industry and the UK primary care sector, and licensing its technology to healthcare publishers. The company's products include BestPathway and Point-of-Care ExpertCare.
39GF Score
Get the complete analysis for STU:7EE
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:7EE has been successfully added to your 
